Uncategorized

Young adults could struggle to navigate government bureaucracy and face other challenges managing work requirements or increased eligibility checks in the safety-net insurance program, the Urban Institute found.

Thornal will join the orthopedics company as group president for global businesses and the Americas, a newly created position.

The agency recommends manufacturers update their vaccines to target the JN.1 strain. At the same time, HHS head Robert F. Kennedy Jr. is removing guidance that healthy children and pregnant women receive COVID shots.

The acquisition of SiteOne provides a bit of diversification for Lilly, which has burrowed into the obesity and diabetes space with mega-blockbuster tirzepatide and several follow-on molecules.

Federal agencies are seeking public feedback on how to improve price transparency around prescription drugs and boost hospital compliance and enforcement.

The duties are slated to take effect July 9 as the bloc and the U.S. reengage on trade talks, the president said.

GlycoEra’s lead candidate targets IgG4 autoantibodies, potentially addressing autoimmune diseases such as muscle-specific kinase myasthenia gravis and pemphigus.

In addition to a $140 million series D, GRIN Therapeutics has signed a global licensing deal for the epilepsy disorder drug radiprodil worth $50 million upfront.

With $90 million to start, Syndeio has a lead asset in Phase II clinical trials for major depressive disorder, with plans to soon launch a biomarker trial in Alzheimer’s disease.

Acute systemic infection caused the patient to develop fatal capillary leak syndrome, highlighting the unpredictability of gene therapies and potentially challenging investment in the space, analysts say.